[Therapeutic impact of alpha interferon in chronic myelogenous leukaemia].;Impact therapeutique de l'interferon alpha dans la prise en charge des patients atteints de leucemie myeloide chronique.

Le Mali médical

Volumn 25, Issue 1, 2010, Pages 22-27

  Tolo Diebkile A ^a   Koffi, K G ^b   Sawadogo, G D ^b   Ndiaye, F S ^b   Nanho, D C ^b   Sekongo Y M ^b   Kouakou, B ^b   Meite N ^b   Ayemou, R ^b   Sanogo, I ^b  

^a CHU de Yopougon

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ANTINEOPLASTIC AGENT; BCR ABL PROTEIN; CYTARABINE; HYDROXYUREA; IMMUNOLOGIC FACTOR;

ADULT; ARTICLE; BLAST CELL CRISIS; BLOOD; EVALUATION; FEMALE; GENETICS; HUMAN; KAPLAN MEIER METHOD; MALE; MIDDLE AGED; MYELOID LEUKEMIA; REMISSION; RETROSPECTIVE STUDY; SOCIOECONOMICS; VIRUS ACTIVATION;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLAST CRISIS; CYTARABINE; FEMALE; FUSION PROTEINS, BCR-ABL; HUMANS; HYDROXYUREA; IMMUNOLOGIC FACTORS; INTERFERON-ALPHA; KAPLAN-MEIER ESTIMATE; LEUKEMIA, MYELOID, CHRONIC-PHASE; MALE; MIDDLE AGED; REMISSION INDUCTION; RETROSPECTIVE STUDIES; SOCIOECONOMIC FACTORS; VIRUS ACTIVATION; YOUNG ADULT;

EID: 77957870180     PISSN: None     EISSN: 19930836     Source Type: Journal    
DOI: None     Document Type: Article

References (0)